AbbVie Statistics

Total Valuation

AbbVie has a market cap or net worth of ARS 317.29 trillion. The enterprise value is 382.81 trillion.

Market Cap	317.29T
Enterprise Value	382.81T

Important Dates

The next estimated earnings date is Friday, January 31, 2025.

Earnings Date	Jan 31, 2025
Ex-Dividend Date	Jan 15, 2025

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	-0.07%
Shares Change (QoQ)	+0.06%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	1.76B

Valuation Ratios

The trailing PE ratio is 64.39.

PE Ratio	64.39
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 14.43, with an EV/FCF ratio of 25.27.

EV / Earnings	77.69
EV / Sales	6.74
EV / EBITDA	14.43
EV / EBIT	21.68
EV / FCF	25.27

Financial Position

The company has a current ratio of 0.65, with a Debt / Equity ratio of 11.75.

Current Ratio	0.65
Quick Ratio	0.44
Debt / Equity	11.75
Debt / EBITDA	2.75
Debt / FCF	4.57
Interest Coverage	6.47

Financial Efficiency

Return on equity (ROE) is 56.41% and return on invested capital (ROIC) is 14.32%.

Return on Equity (ROE)	56.41%
Return on Assets (ROA)	7.72%
Return on Capital (ROIC)	14.32%
Revenue Per Employee	1.08B
Profits Per Employee	98.55M
Employee Count	50,000
Asset Turnover	0.40
Inventory Turnover	3.91

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +37.88% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+37.88%
50-Day Moving Average	20,919.50
200-Day Moving Average	21,432.76
Relative Strength Index (RSI)	54.94
Average Volume (20 Days)	742

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	3.10

Income Statement

In the last 12 months, AbbVie had revenue of ARS 53.86 trillion and earned 4.93 trillion in profits. Earnings per share was 2,783.24.

Revenue	53.86T
Gross Profit	37.88T
Operating Income	16.75T
Pretax Income	6.98T
Net Income	4.93T
EBITDA	24.86T
EBIT	16.75T
Earnings Per Share (EPS)	2,783.24

Full Income Statement

Balance Sheet

The company has 7.06 trillion in cash and 69.17 trillion in debt, giving a net cash position of -62,104.05 billion.

Cash & Cash Equivalents	7.06T
Total Debt	69.17T
Net Cash	-62,104.05B
Net Cash Per Share	n/a
Equity (Book Value)	5.89T
Book Value Per Share	3,310.41
Working Capital	-14,815.63B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 16.01 trillion and capital expenditures -861.18 billion, giving a free cash flow of 15.15 trillion.

Operating Cash Flow	16.01T
Capital Expenditures	-861.18B
Free Cash Flow	15.15T
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 70.33%, with operating and profit margins of 31.10% and 9.22%.

Gross Margin	70.33%
Operating Margin	31.10%
Pretax Margin	12.96%
Profit Margin	9.22%
EBITDA Margin	46.15%
EBIT Margin	31.10%
FCF Margin	28.13%

Dividends & Yields

This stock pays an annual dividend of 350.87, which amounts to a dividend yield of 1.75%.

Dividend Per Share	350.87
Dividend Yield	1.75%
Dividend Growth (YoY)	209.24%
Years of Dividend Growth	3
Payout Ratio	212.79%
Buyback Yield	0.07%
Shareholder Yield	1.82%
Earnings Yield	n/a
FCF Yield	n/a

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

AbbVie has an Altman Z-Score of 1.9. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.9
Piotroski F-Score	n/a